The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nephrology Drugs Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Nephrology Drugs Market
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
The global Nephrology Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, ACE Inhibitors accounting for % of the Nephrology Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Nephrology Drugs market size is valued at US$ million in 2021, while the North America and Europe Nephrology Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nephrology Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nephrology Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nephrology Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nephrology Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nephrology Drugs market.
Global Nephrology Drugs Scope and Market Size
Nephrology Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nephrology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
Market Analysis and Insights: Global Nephrology Drugs Market
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
The global Nephrology Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, ACE Inhibitors accounting for % of the Nephrology Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Nephrology Drugs market size is valued at US$ million in 2021, while the North America and Europe Nephrology Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nephrology Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nephrology Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nephrology Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nephrology Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nephrology Drugs market.
Global Nephrology Drugs Scope and Market Size
Nephrology Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nephrology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nephrology Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 ACE Inhibitors
1.2.3 Calcium Channel Blocker
1.2.4 Beta Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nephrology Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nephrology Drugs Market Perspective (2017-2028)
2.2 Nephrology Drugs Growth Trends by Region
2.2.1 Nephrology Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nephrology Drugs Historic Market Size by Region (2017-2022)
2.2.3 Nephrology Drugs Forecasted Market Size by Region (2023-2028)
2.3 Nephrology Drugs Market Dynamics
2.3.1 Nephrology Drugs Industry Trends
2.3.2 Nephrology Drugs Market Drivers
2.3.3 Nephrology Drugs Market Challenges
2.3.4 Nephrology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nephrology Drugs Players by Revenue
3.1.1 Global Top Nephrology Drugs Players by Revenue (2017-2022)
3.1.2 Global Nephrology Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Nephrology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nephrology Drugs Revenue
3.4 Global Nephrology Drugs Market Concentration Ratio
3.4.1 Global Nephrology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nephrology Drugs Revenue in 2021
3.5 Nephrology Drugs Key Players Head office and Area Served
3.6 Key Players Nephrology Drugs Product Solution and Service
3.7 Date of Enter into Nephrology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nephrology Drugs Breakdown Data by Type
4.1 Global Nephrology Drugs Historic Market Size by Type (2017-2022)
4.2 Global Nephrology Drugs Forecasted Market Size by Type (2023-2028)
5 Nephrology Drugs Breakdown Data by Application
5.1 Global Nephrology Drugs Historic Market Size by Application (2017-2022)
5.2 Global Nephrology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nephrology Drugs Market Size (2017-2028)
6.2 North America Nephrology Drugs Market Size by Country (2017-2022)
6.3 North America Nephrology Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nephrology Drugs Market Size (2017-2028)
7.2 Europe Nephrology Drugs Market Size by Country (2017-2022)
7.3 Europe Nephrology Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nephrology Drugs Market Size (2017-2028)
8.2 Asia-Pacific Nephrology Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Nephrology Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nephrology Drugs Market Size (2017-2028)
9.2 Latin America Nephrology Drugs Market Size by Country (2017-2022)
9.3 Latin America Nephrology Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nephrology Drugs Market Size (2017-2028)
10.2 Middle East & Africa Nephrology Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Nephrology Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Nephrology Drugs Introduction
11.1.4 AstraZeneca Revenue in Nephrology Drugs Business (2017-2022)
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Nephrology Drugs Introduction
11.2.4 Pfizer Revenue in Nephrology Drugs Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Nephrology Drugs Introduction
11.3.4 Amgen Revenue in Nephrology Drugs Business (2017-2022)
11.3.5 Amgen Recent Development
11.4 FibroGen
11.4.1 FibroGen Company Detail
11.4.2 FibroGen Business Overview
11.4.3 FibroGen Nephrology Drugs Introduction
11.4.4 FibroGen Revenue in Nephrology Drugs Business (2017-2022)
11.4.5 FibroGen Recent Development
11.5 GlaxoSmithkline
11.5.1 GlaxoSmithkline Company Detail
11.5.2 GlaxoSmithkline Business Overview
11.5.3 GlaxoSmithkline Nephrology Drugs Introduction
11.5.4 GlaxoSmithkline Revenue in Nephrology Drugs Business (2017-2022)
11.5.5 GlaxoSmithkline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Nephrology Drugs Introduction
11.6.4 AbbVie Revenue in Nephrology Drugs Business (2017-2022)
11.6.5 AbbVie Recent Development
11.7 Akebia Therapeutics
11.7.1 Akebia Therapeutics Company Detail
11.7.2 Akebia Therapeutics Business Overview
11.7.3 Akebia Therapeutics Nephrology Drugs Introduction
11.7.4 Akebia Therapeutics Revenue in Nephrology Drugs Business (2017-2022)
11.7.5 Akebia Therapeutics Recent Development
11.8 Teva Pharmaceutical Industries
11.8.1 Teva Pharmaceutical Industries Company Detail
11.8.2 Teva Pharmaceutical Industries Business Overview
11.8.3 Teva Pharmaceutical Industries Nephrology Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2017-2022)
11.8.5 Teva Pharmaceutical Industries Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Detail
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Nephrology Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Nephrology Drugs Business (2017-2022)
11.9.5 Johnson & Johnson Recent Development
11.10 Roche
11.10.1 Roche Company Detail
11.10.2 Roche Business Overview
11.10.3 Roche Nephrology Drugs Introduction
11.10.4 Roche Revenue in Nephrology Drugs Business (2017-2022)
11.10.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Nephrology Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of ACE Inhibitors
Table 3. Key Players of Calcium Channel Blocker
Table 4. Key Players of Beta Blockers
Table 5. Key Players of Diuretics
Table 6. Key Players of Others
Table 7. Global Nephrology Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Nephrology Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Nephrology Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Nephrology Drugs Market Share by Region (2017-2022)
Table 11. Global Nephrology Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Nephrology Drugs Market Share by Region (2023-2028)
Table 13. Nephrology Drugs Market Trends
Table 14. Nephrology Drugs Market Drivers
Table 15. Nephrology Drugs Market Challenges
Table 16. Nephrology Drugs Market Restraints
Table 17. Global Nephrology Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Nephrology Drugs Market Share by Players (2017-2022)
Table 19. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2021)
Table 20. Ranking of Global Top Nephrology Drugs Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Nephrology Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nephrology Drugs Product Solution and Service
Table 24. Date of Enter into Nephrology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nephrology Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Nephrology Drugs Revenue Market Share by Type (2017-2022)
Table 28. Global Nephrology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Nephrology Drugs Revenue Market Share by Type (2023-2028)
Table 30. Global Nephrology Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Nephrology Drugs Revenue Market Share by Application (2017-2022)
Table 32. Global Nephrology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Nephrology Drugs Revenue Market Share by Application (2023-2028)
Table 34. North America Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Nephrology Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Nephrology Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Nephrology Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Nephrology Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. AstraZeneca Company Detail
Table 45. AstraZeneca Business Overview
Table 46. AstraZeneca Nephrology Drugs Product
Table 47. AstraZeneca Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 48. AstraZeneca Recent Development
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Nephrology Drugs Product
Table 52. Pfizer Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Nephrology Drugs Product
Table 57. Amgen Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. FibroGen Company Detail
Table 60. FibroGen Business Overview
Table 61. FibroGen Nephrology Drugs Product
Table 62. FibroGen Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 63. FibroGen Recent Development
Table 64. GlaxoSmithkline Company Detail
Table 65. GlaxoSmithkline Business Overview
Table 66. GlaxoSmithkline Nephrology Drugs Product
Table 67. GlaxoSmithkline Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 68. GlaxoSmithkline Recent Development
Table 69. AbbVie Company Detail
Table 70. AbbVie Business Overview
Table 71. AbbVie Nephrology Drugs Product
Table 72. AbbVie Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 73. AbbVie Recent Development
Table 74. Akebia Therapeutics Company Detail
Table 75. Akebia Therapeutics Business Overview
Table 76. Akebia Therapeutics Nephrology Drugs Product
Table 77. Akebia Therapeutics Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 78. Akebia Therapeutics Recent Development
Table 79. Teva Pharmaceutical Industries Company Detail
Table 80. Teva Pharmaceutical Industries Business Overview
Table 81. Teva Pharmaceutical Industries Nephrology Drugs Product
Table 82. Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Johnson & Johnson Company Detail
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Nephrology Drugs Product
Table 87. Johnson & Johnson Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Roche Company Detail
Table 90. Roche Business Overview
Table 91. Roche Nephrology Drugs Product
Table 92. Roche Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million)
Table 93. Roche Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nephrology Drugs Market Share by Type: 2021 VS 2028
Figure 2. ACE Inhibitors Features
Figure 3. Calcium Channel Blocker Features
Figure 4. Beta Blockers Features
Figure 5. Diuretics Features
Figure 6. Others Features
Figure 7. Global Nephrology Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Nephrology Drugs Report Years Considered
Figure 12. Global Nephrology Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Nephrology Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Nephrology Drugs Market Share by Region: 2021 VS 2028
Figure 15. Global Nephrology Drugs Market Share by Players in 2021
Figure 16. Global Top Nephrology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nephrology Drugs as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Nephrology Drugs Revenue in 2021
Figure 18. North America Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Nephrology Drugs Market Share by Country (2017-2028)
Figure 20. United States Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Nephrology Drugs Market Share by Country (2017-2028)
Figure 24. Germany Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Nephrology Drugs Market Share by Region (2017-2028)
Figure 32. China Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Nephrology Drugs Market Share by Country (2017-2028)
Figure 40. Mexico Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Nephrology Drugs Market Share by Country (2017-2028)
Figure 44. Turkey Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Nephrology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 47. Pfizer Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 48. Amgen Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 49. FibroGen Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 50. GlaxoSmithkline Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 51. AbbVie Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 52. Akebia Therapeutics Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 53. Teva Pharmaceutical Industries Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 55. Roche Revenue Growth Rate in Nephrology Drugs Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
